LitCovid-sentences  

PubMed:33134948 JSONTXT 19 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 0-156 Sentence denotes A Method to Improve Continuous Renal Replacement Therapy Circuit Survival Time in Critically Ill Coronavirus Disease 2019 Patients With Acute Kidney Injury.
T2 157-168 Sentence denotes Objectives:
T3 169-291 Sentence denotes Optimizing continuous renal replacement therapy circuit survival in coronavirus disease 2019 patients admitted to the ICU.
T4 292-299 Sentence denotes Design:
T5 300-353 Sentence denotes Single-center prospective observational cohort study.
T6 354-362 Sentence denotes Setting:
T7 363-394 Sentence denotes Tertiary academic teaching ICU.
T8 395-404 Sentence denotes Patients:
T9 405-607 Sentence denotes Between March 19, 2020, and May 18, 2020, 11 out of 101 coronavirus disease 2019 patients were treated with continuous renal replacement therapy comprising 127 continuous renal replacement therapy days.
T10 608-622 Sentence denotes Interventions:
T11 623-910 Sentence denotes A nonrandomized observational comparison of circuit anticoagulation modalities using standard regional citrate anticoagulation, continuous IV heparin anticoagulation, or the combination of regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin.
T12 911-941 Sentence denotes Measurements and Main Results:
T13 942-1073 Sentence denotes Circuit patency was shorter than 24 hours using standard regional citrate anticoagulation or continuous IV heparin anticoagulation.
T14 1074-1261 Sentence denotes Median circuit survival increased with at least 165% when the combination of regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin was applied.
T15 1262-1274 Sentence denotes Conclusions:
T16 1275-1383 Sentence denotes Continuous renal replacement therapy circuit patency is diminished in coronavirus disease 2019 ICU patients.
T17 1384-1616 Sentence denotes Combining regional citrate anticoagulation with either continuous IV heparin or therapeutic dose nadroparin increases filter survival as compared with regional citrate anticoagulation alone in this nonrandomized observational study.